文献速递系统性红斑狼疮

2019年EULAR/ACR系统性红斑狼疮分类标准在儿童及年轻成人中的效能

Performance of the New 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in Children and Young Adults.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-01-01

该研究在112例SLE患者(2-21岁)和105例对照(1-19岁,含幼年皮肌炎、幼年硬皮病或幼年系统性硬化症)中比较2019年EULAR/ACR与1997年ACR分类标准的诊断效能。结果显示2019年标准敏感性显著更高(85% vs 72%,P=0.023),特异性相似(83% vs 87%,P=0.456),且敏感性不受年龄或性别影响。

要点

  • 2019年EULAR/ACR标准在≤21岁SLE患者中敏感性显著高于1997年ACR标准(85% vs 72%,P=0.023)。
  • 两标准特异性相似(83% vs 87%,P=0.456)。
  • 2019年标准敏感性不受年龄或性别影响,非白人与白人敏感性差异无统计学意义。

核心结论

  • 2019年EULAR/ACR标准能有效分类儿童及年轻成人SLE,且敏感性显著高于1997年ACR标准,特异性相似。

研究设计与样本

  • 回顾性研究,数据来自大型学术儿科医院电子健康记录,以风湿科医生诊断为金标准,纳入112例SLE患者(2-21岁)和105例对照(1-19岁,66%幼年皮肌炎,34%幼年硬皮病或幼年系统性硬化症)。

主要发现

  • 2019年EULAR/ACR标准敏感性85%,1997年ACR标准72%(P=0.023);特异性分别为83%和87%(P=0.456)。
  • 非白人患者2019年EULAR/ACR分类总结评分均值±SD为22.41±10.04,显著高于白人患者的17.59±9.19(P<0.01)。
  • 2019年标准在非白人/白人中的敏感性为92%/80%(P=0.08),1997年标准为83%/64%(P<0.02)。
  • 2019年EULAR/ACR标准的敏感性不受年龄或性别影响。

关键数值与推荐

  • 非白人患者2019年EULAR/ACR分类总结评分均值±SD为22.41±10.04,白人为17.59±9.19(P<0.01)。

临床怎么用

  • 在≤21岁疑似SLE患者中,可优先采用2019年EULAR/ACR分类标准以提高诊断敏感性,同时保持与1997年标准相似的特异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the diagnostic usefulness of the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus (SLE) to that of the 1997 ACR classification criteria for SLE when applied to youths (age ≤21 years) with SLE. METHODS: Data were extracted from electronic health records of patients followed at a large academic pediatric hospital. The treating rheumatologist's diagnosis of SLE served as the standard criterion for identifying SLE patients (cases). Controls were patients with juvenile dermatomyositis (DM), juvenile scleroderma, or juvenile systemic sclerosis (SSc). The 2019 EULAR/ACR criteria and the 1997 ACR criteria were tested against the standard criterion. RESULTS: A total of 112 SLE patients ages 2-21 years and 105 controls ages 1-19 years (66% juvenile DM, 34% juvenile scleroderma or juvenile SSc) were available for analysis. The 2019 EULAR/ACR criteria had significantly higher sensitivity (85% versus 72%; P = 0.023) and similar specificity (83% versus 87%; P = 0.456) than the 1997 ACR criteria. The mean ± SD 2019 EULAR/ACR classification summary scores were significantly higher among non-White than White patients (22.41 ± 10.04 versus 17.59 ± 9.19; P < 0.01). The sensitivity of the 2019 EULAR/ACR criteria in non-White/White patients was 92%/80% (P = 0.08) versus 83%/64% (P < 0.02) for the 1997 ACR criteria. The sensitivity of the 2019 EULAR/ACR criteria was not affected by age or sex. CONCLUSION: The 2019 EULAR/ACR criteria efficiently classify youths with SLE, irrespective of age, sex, and race. Compared to the 1997 ACR criteria, the new criteria are significantly more sensitive and similarly specific in youths with SLE.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Aljaberi N, Nguyen K, Strahle C, et al. Performance of the New 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in Children and Young Adults. Arthritis Care Res (Hoboken). 2021. PMID: 32841547. doi:10.1002/acr.24430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。